🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
GSK2798745 is a potent and selective transient receptor potential vanilloid...
Status
Terminated
Location
GSK Investigational Site
Start Date
2018-04-05
Trial ID
NCT03372603
Treatments Being Tested
A double-blind, randomized, placebo-controlled, parallel-group, multi-site,...
Status
Completed
Location
Cook Street Medical Clinic
Start Date
2022-08-26
Trial ID
NCT05248386
Treatments Being Tested
This will be a FTIH study which aims to evaluate safety, tolerability, phar...
Status
Terminated
Location
GSK Investigational Site
Start Date
2021-09-20
Trial ID
NCT05044325
Treatments Being Tested
Human African trypanosomiasis (HAT) or sleeping sickness is a tropical dise...
Status
Completed
Location
General Referral Hospital of Bagata
Start Date
2021-12-30
Trial ID
NCT05256017
Treatments Being Tested
This is a Phase I Randomised Single-blind Placebo-controlled Study to Asses...
Status
Completed
Location
Research Site
Start Date
2023-05-02
Trial ID
NCT05848440
The primary objective of the study is to evaluate the efficacy of BIIB104 i...
Status
Completed
Location
Pillar Clinical Research, LLC
Start Date
2018-11-15
Trial ID
NCT03745820
ACTT-2 will evaluate the combination of baricitinib and remdesivir compared...
Status
Completed
Location
University of Alabama at Birmingham School of Medicine - Infectious Disease
Start Date
2020-05-08
Trial ID
NCT04401579
Treatments Being Tested
This randomized, multicenter, double-blind, placebo-controlled, parallel-gr...
Status
Completed
Location
University Alabama At Birmingham
Start Date
2013-10-13
Trial ID
NCT01872689
Treatments Being Tested
This Study Aims to Evaluate the Safety, Tolerability and Efficacy of R2R01 ...
Status
Completed
Location
Thomas Hospital
Start Date
2024-03-01
Trial ID
NCT06264310
This is a multicenter, randomized, double-blind, placebo-controlled, parall...
Status
Completed
Location
Clinical Site
Start Date
2023-03-13
Trial ID
NCT05766813
Treatments Being Tested